Literature DB >> 6106796

Iron chelation with oral desferrioxamine.

S T Callender, D J Weatherall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6106796     DOI： 10.1016/s0140-6736(80)92721-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Susceptibilities of bacterial and fungal urinary tract isolates to desferrioxamine.

Authors:  F D Lowy; S Pollack; N Fadl-Allah; N H Steigbigel
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

Review 2.  Management of the thalassemias.

Authors:  Nancy F Olivieri; Gary M Brittenham
Journal:  Cold Spring Harb Perspect Med       Date:  2013-06-01       Impact factor: 6.915

Review 3.  Present status and future prospects of oral iron chelation therapy in thalassaemia and other diseases.

Authors:  G J Kontoghiorghes
Journal:  Indian J Pediatr       Date:  1993 Jul-Aug       Impact factor: 1.967

Review 4.  Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine.

Authors:  George J Kontoghiorghes; Katia Neocleous; Annita Kolnagou
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

5.  Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.

Authors:  G J Kontoghiorghes; M A Aldouri; A V Hoffbrand; J Barr; B Wonke; T Kourouclaris; L Sheppard
Journal:  Br Med J (Clin Res Ed)       Date:  1987-12-12

6.  Curcumin Attenuates Iron Accumulation and Oxidative Stress in the Liver and Spleen of Chronic Iron-Overloaded Rats.

Authors:  Farid A Badria; Ahmed S Ibrahim; Adel F Badria; Ahmed A Elmarakby
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.